Pre-treatment with GnRH agonists for 36 months prior to ovarian stimulation may improve ART outcomes by reducing pelvic inflammation
for the use of topical cyclosporine
Bignon J, Khoury F, Even P, Andre J, Brouet G: Morphometric study in chronic obstructive bronchopulmonary disease
It is specifically characterized by inflammation, demyelination, and neuronal loss and manifests with a range of neurological symptoms including numbness, tingling, vision impairment, cognitive impairment, and bladder and bowel dysfunction (Tafti et al., 2024)
They can also recommend treatments for specific side effects where necessary